News Focus
News Focus
icon url

entdoc

09/17/12 5:42 PM

#92737 RE: cjgaddy #92726

cj, thanks. It is SO gratifying to see how far this anti-PS platform has come under the insight and stewardship of Dr. Philip Thorpe, our intrepid science helmsman (no offence FTM). Many of us vividly remember the naysayers who cast dispersions on his ability and knowledge. Years ago I said his was Nobel quality work, and there are echoes of that here now, and the many spin-offs from that platform continue to grow apace. Great stuff. Thorpe chairing a conference of that quality speaks volumes.
icon url

horselover45

09/17/12 6:30 PM

#92738 RE: cjgaddy #92726

CJ---Did you ever get a reply from IR about our question on the MOS for the control group in the first NCSLC trial??

Cris told me among other things that it was a material event and would be released when it happened.It is hard to believe that it hasn't been reached as of this date.
icon url

entdoc

09/17/12 6:33 PM

#92739 RE: cjgaddy #92726

cj, thanks. Thorpe chairing the tumor immunology confab is evidence of how far PPHM's anti-PS platform has come under the insight and stewardship of Dr. Philip Thorpe, PPHM's lead science (UTSW Prof., Dept.Pharm). I'll keep my money on Thorpe, UTSW, and PPHM. Remember the naysayers? Years ago I said Thorpe's work was Nobel quality, and echoes of that are beginning to be audible. The value Bavi, even the spin-offs from the aniti-PS platform, grow apace with each new report and discovery. Great stuff. Thorpe chairing a the tumor immunology conference speaks volumes. Fab.